Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Adoptive T Cell Therapy / CAR-T in Large B-cell lymphoma (LBCL) / Diffuse Large B-Cell Lymphoma (DLBCL) mainly refers to CD19-directed CAR-T therapy, which has become a major treatment option for relapsed or refractory disease and has expanded from third-line use into second-line settings for selected patients.
Recent advances in immunotherapy such as chimeric antigen receptor T-cell therapy have significantly improved the outcomes in patients.
Dong et al. 2023 Expert Opi…